Clinical Trials of Multivalent Opioid Vaccine Components
Public ClinicalTrials.gov record NCT04458545. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1A/1B Clinical Trials of Multivalent Opioid Vaccine Components
Study identification
- NCT ID
- NCT04458545
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- New York State Psychiatric Institute
- Other
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Interventions
- Oxy(Gly)4-sKLH vaccine - High Dose Biological
- Oxy(Gly)4-sKLH vaccine - Low Dose Biological
- Placebo Oxy(Gly)4-sKLH vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 59 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2020
- Primary completion
- Mar 29, 2027
- Completion
- Mar 29, 2027
- Last update posted
- Apr 22, 2026
2020 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinilabs Drug Development Corporation | Eatontown | New Jersey | 07724 | Recruiting |
| New York State Psychiatric Institute: Division on Substance Use Disorders | New York | New York | 10032 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04458545, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04458545 live on ClinicalTrials.gov.